SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma’s unit recalling 3,094 cartons of Acetaminophen injection

15 Feb 2021 Evaluate

AuroMedics Pharma LLC, a unit of Hyderabad-based Aurobindo Pharma, is recalling 3,094 cartons of Acetaminophen injection. The drug is used to relieve mild to moderate pain and reduce fever.

AuroMedics Pharma is recalling affected lots of Acetaminophen injection which have been produced in India. The company is recalling the lot due to ‘discoloration and failed pH specifications’. AuroMedics initiated the nationwide recall on December 30, 2020.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1405.95 14.80 (1.06%)
22-Apr-2026 12:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1659.70
Dr. Reddys Lab 1220.00
Cipla 1234.20
Zydus Lifesciences 930.20
Lupin 2305.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×